Lipid signaling pathway enables epithelial cells to survive bacterial toxin damage

The cell pinches off the damaged section and ejects it as a tiny bubble
Epithelial cells use a lipid signaling pathway to shed toxin-damaged membrane pieces as extracellular vesicles.
Mark

So epithelial cells are just sitting there getting attacked by toxins all day. How do they normally survive?

Mimi

They have repair systems that activate after damage occurs. This study identified one of them—a lipid signaling pathway that kicks in when calcium floods through a toxin pore.

Mark

And this pathway does what, exactly?

Mimi

Two things at once. The cell sheds the damaged membrane piece as a tiny vesicle, essentially cutting off the wound. And it reorganizes its internal scaffolding to reinforce the injury site.

Luke

But the study only tested this in cells grown in dishes, right? With four specific toxins?

Mimi

Yes. Three different cell types, four different toxins. The consistency across all of them suggests it's a general system, not specific to one bacterial threat.

Mark

If we could boost this pathway, could we make cells more resistant to infection?

Mimi

That's the hypothesis. The researchers suggest therapies could enhance this defense mechanism to help tissues withstand bacterial attacks.

Luke

Has anyone tested that in animals yet?

Mimi

Not according to this paper. This is the discovery phase. The next step would be in vivo studies.

Mark

So we're looking at years before any actual treatment?

Mimi

Probably. But the pathway itself is now mapped. That's the foundation.

Luke

One more thing—the study shows BLT2 helps cells survive, but it doesn't prevent the toxin from attaching in the first place. So it's damage control, not prevention.

Mimi

Exactly. It's a response mechanism, not a barrier.

  • Bacteria deploy pore-forming toxins that bore holes in cell membranes, and without rapid repair, the cell hemorrhages its contents and dies — making this a race between destruction and survival.
  • Across three cell types and four different toxins, cells lacking the BLT2 receptor ruptured and died at significantly higher rates, revealing how critical this single molecular pathway is to frontline tissue defense.
  • The repair system activates in two simultaneous moves: the cell amputates the damaged membrane section by ejecting it as an extracellular vesicle, while internally reorganizing its actin scaffolding through the protein Rac1 to reinforce the injury site.
  • Blocking either repair mechanism alone was enough to strip BLT2 of its protective power, confirming that both actions must work in concert — a finding that sharpens the target for future therapeutic design.
  • The research opens a complementary front in infection medicine: rather than only attacking pathogens or neutralizing their toxins, therapies might instead be designed to amplify the host cell's own capacity to survive damage.

At the boundary between self and world, the cells lining our lungs, skin, and gut wage a quiet war against bacterial toxins designed to puncture and destroy them. Researchers at Juntendo University have now illuminated a previously hidden repair system — a lipid signaling pathway involving 12-HHT and its receptor BLT2 — that allows epithelial cells to patch their own wounds after toxin attack, not by stopping the assault, but by responding to it with remarkable cellular ingenuity. Published in the Journal of Cell Biology in September 2026, the findings reframe infection resilience as not merely a matter of defeating the pathogen, but of fortifying the living tissue that must endure it.

The cells lining your lungs, skin, and gut are your body's first wall against the world — and some bacteria have evolved toxins that punch holes straight through them, like microscopic drills boring into the membrane until the cell can no longer hold itself together. If the wound cannot be sealed in time, the cell dies. Researchers at Juntendo University, led by Dr. Yuan Chi, Dr. Kazuko Saeki, and Professor Takehiko Yokomizo, have now identified a previously unknown repair system that keeps these frontline cells alive — a lipid signaling pathway built around a bioactive molecule called 12-HHT and its receptor, BLT2.

The team tested the pathway across three different cell types and deliberately damaged them using four distinct pore-forming toxins, including pneumolysin and streptolysin O. Cells with enhanced BLT2 signaling leaked less, sustained less visible damage, maintained healthier mitochondria, and survived at higher rates. Cells stripped of BLT2 ruptured and died far more readily. The consistency across all four toxins suggested this is a general defense mechanism, not a narrow response to any single threat.

Critically, BLT2 does not stop toxins from attaching to the cell. It activates after the damage has already begun. When a pore opens, calcium floods in, triggering the cell to produce 12-HHT, which binds to BLT2 and launches two simultaneous repair actions: the cell pinches off the damaged membrane section — toxin pore and all — and ejects it as a tiny extracellular vesicle, while the protein Rac1 reorganizes the cell's internal actin scaffolding to reinforce the injured area. Blocking either mechanism alone was enough to eliminate BLT2's protective effect, confirming that both are essential.

The implications reach beyond the laboratory. Most approaches to bacterial infection focus on killing the pathogen or neutralizing its weapons. This research points toward a complementary strategy — enhancing the host cell's own resilience. If the 12-HHT/BLT2 pathway can be therapeutically amplified in living organisms, it may one day allow tissues to survive infections that would otherwise overwhelm them.

The cells that line your lungs, skin, and gut stand as your body's first wall against the world. They face constant assault—bacteria, viruses, toxins, all pressing against them. Some bacteria have evolved a particularly brutal weapon: toxins that punch holes in cell membranes like microscopic drills, boring through the protective barrier and letting the cell's contents spill out. If a cell cannot seal these wounds quickly enough, it dies. Understanding how epithelial cells survive this kind of damage has become a central question in infection biology, and researchers at Juntendo University have now identified a previously unknown repair system that keeps these frontline defenders alive.

Dr. Yuan Chi, Dr. Kazuko Saeki, and Professor Takehiko Yokomizo focused their investigation on a signaling pathway involving two molecular players: 12-HHT, a bioactive lipid, and BLT2, a receptor found mainly on epithelial cells. They wanted to know whether this pathway could explain how cells rapidly patch themselves after toxin damage. The work, published in the Journal of Cell Biology in early September 2026, reveals a two-part repair mechanism that cells activate in response to membrane injury.

The team tested their hypothesis using three different cell types: human lung epithelial cells, canine kidney epithelial cells, and mouse skin cells. They compared cells with normal BLT2 levels, cells engineered to produce more BLT2, and cells with no BLT2 at all. Then they deliberately damaged the cells using four different pore-forming toxins—pneumolysin, streptolysin O, and α-hemolysin from bacteria, plus digitonin, a chemical that mimics toxin damage. Using microscopy, fluorescent dyes, enzyme assays, and electron microscopy, they measured how much the membranes leaked, how much visible damage appeared, whether mitochondria remained healthy, and whether cells survived. The results were clear: cells with enhanced BLT2 signaling leaked less, looked less damaged, kept their mitochondria functioning better, and lived longer. Cells without BLT2 ruptured and died at higher rates. The effect held across all four toxins, suggesting the pathway is part of a general cellular defense system rather than a response to one specific threat.

What the researchers discovered is that BLT2 does not prevent toxins from attaching to the cell in the first place. Instead, it activates after injury has already occurred. When a toxin pore opens, calcium floods into the cell through the hole. This calcium surge triggers the cell to produce 12-HHT. The 12-HHT then binds to BLT2 and sets off two simultaneous repair actions. First, the cell pinches off the damaged section of membrane—including the toxin pore itself—and ejects it as a tiny bubble called an extracellular vesicle, essentially amputating the wound. Second, BLT2 activates a protein called Rac1, which reorganizes actin, the cell's internal scaffolding, to reinforce and reshape the injured area. When researchers blocked either of these mechanisms, BLT2 lost its protective power, confirming that both repair actions are essential.

The implications extend beyond basic biology. Current approaches to bacterial infection focus almost entirely on killing the pathogen or neutralizing its toxins. This research suggests a complementary strategy: enhancing the host cell's own ability to withstand and repair damage. By understanding the 12-HHT/BLT2 pathway, researchers may eventually develop therapies that strengthen epithelial cells' defenses, allowing tissues to survive infections that would otherwise overwhelm them. The next step will be testing whether this pathway can be therapeutically enhanced in living organisms, and whether doing so actually improves outcomes in bacterial infections.

These findings identify the 12-HHT/BLT2 axis as a previously unrecognized regulator of the cellular response to plasma membrane damage.
— Dr. Yuan Chi, Juntendo University
In addition to targeting the pathogen or toxin, it may also be possible to enhance the ability of host cells to withstand and repair membrane damage.
— Dr. Yuan Chi, Juntendo University
Möchten Sie die ganze Geschichte? Das Original lesen bei News-Medical ↗
Kontakt FAQ